PodcastAmplify Search the directory
DI
Artwork for Data in Biotech
Tech · General

Data in Biotech

Hosted by CorrDyn.

Show website ↗ Listen on Apple ↗

Should you pitch it?

Guest activity
Sometimes has guests
40% of recent episode titles look like interviews
Episode length
57 min
Median of recent episodes. That is the commitment you would be asking for.
Publishing
Monthly
77 episodes · last 2026-09-02
Language
English
The feed says "en" without a region, so the country is unknown.
Where it's from
Not established
No .uk domain and no region in the feed language. Apple reports the storefront, not the show, so we do not guess.
Reach
60
Percentile among shows you could realistically get on. Not a download count.
Check whether they charge. Some shows sell guest slots rather than booking them, and rates in some fields run to thousands. Nothing in a podcast feed reliably says so, so we do not claim either way. Ask before you write the pitch.
Worth a pitch. This show publishes its own contact, sits outside the national chart, is independently published, and its recent episodes show it books guests.

What the show says about itself

Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter strategic decisions - at www.corrdyn.com

Recent episodes

Straight from the feed. The quickest way to judge whether your angle fits.

  1. How to Identify the Blind Spots in Your Biotech's Genomic Data Before They Cost You a Drug Target
  2. How to Turn Single-Cell Data Into a New Class of Cell-Depleting Therapies
  3. Why Biotech Talks About AI But Won't Pay for the Data It Needs
  4. Beyond Language: Why Drug Discovery Needs Physical AI, Not Just Large Language Models
  5. Synthesizable by Design: Rethinking AI's Role in Small Molecule Drug Discovery
  6. From Tissue to Mechanism to Decision: Building AI for Computational Oncology

This show publishes a contact

We hold the address this show publishes in its own feed. Addresses and drafted pitches are part of a plan. Browsing stays free, and we never send on your behalf.

Tell me when pitching opens